ABSTRACT Anemia is a condition that affects over 1.6 billion people worldwide untreated, the disease could lead to increased morbidity and mortality during pregnancy, affecting both the mother and the unborn child. This paper presents the measured dielectric properties of whole blood samples from 176 patients obtained from a hematology clinic; with 80 samples from male patients and 96 samples from female patients. Measurements were performed using a Keysight slim form probe and Keysight network analyzer to obtain the dielectric properties over a wide frequency range (500 MHz-8.5 GHz). A multiple linear regression analysis is performed to identify which components of the blood show the highest correlation with changes in the dielectric properties. Hemoglobin (Hgb) is shown to be the biggest predictor of changes in complex permittivity, demonstrating that permittivity measurements at a single frequency can potentially be used to detect anemia. A support vector machines algorithm is trained and tested to classify between blood samples from healthy patients and blood samples from patients with anemia. The classifier is optimized using a Bayesian-optimization approach during 10-fold cross-validation and then the average performance of the final trained classifier is evaluated through 10-fold testing on unseen data sets. Using a clinical definition of anemia defined as patients having a concentration of Hgb < 12.0g/dL, the trained classifier has an average sensitivity of 96.89% and specificity of 94.56%. These results demonstrate the potential for a low-cost resonant microwave device to be used to accurately detect the onset of anemia. 
I. INTRODUCTION
Anemia, defined by the World Health Organization (WHO) as the reduction in hemoglobin concentration below 12.0 g/dL, is a condition that affects over 1.6 billion people worldwide [1] , [2] . While the prevalence of the disease in highly developed countries is only 9%, the prevalence is estimated to be 43% in low income countries [1] . Furthermore, those most at risk are children under 5 years of age and pregnant women, with an estimated prevalence of the disease in these two populations of 47% and 42%, respectively [1] , [2] . Untreated, the disease is linked to an increased risk of impaired mental development, impaired immune system function, decreased neurological function, and increased morbidity and mortality during pregnancy, affecting both the mother and the unborn child [3] , [4] . It can similarly affect outcomes of patients with malignant disorders, cardiovascular disease, and increases the risk for transfusion in surgical patients [3] , [4] . While there are simple and effective treatments for anemia (primarily changes in dietary nutrition [1] , [2] , [4] , [5] ), those most at risk are often undiagnosed with the disease; highlighting the need for a low-cost, easily transportable, and easily usable diagnostic tool to assess the presence of anemia in these atrisk populations [1] .
The current gold standard method of assessing hemoglobin (Hgb) concentration is using the direct cyanmethemoglobin method on venous blood samples [1] , [3] , [5] - [7] ; a technique that requires dedicated laboratory equipment to produce a complete blood count (CBC). Furthermore, there are additional physical requirements on this method including: the lysing of red blood cells (RBCs), treating and diluting the whole blood sample, and the need for proximity to where the blood is collected [3] , [6] , [7] . Thus, there is a strong clinicalneed for alternative methods for anemia testing, particularly in geographically remote areas [3] .
Microwave devices have been shown to offer possibilities for both diagnostic and therapeutic medical applications [8] - [11] . These microwave devices can exploit recent advances in telecommunication hardware for the development of compact, non-destructive, and low-cost solutions [12] . The design of these devices is highly dependent on accurate knowledge of the dielectric properties of the various tissues that the device will be interacting with; incorporating these properties into computational and physical models allows for the accurate assessment of the safety, efficacy, and the technical limitations of the devices [13] .
One of the most cited works on the broadband characterization of blood was completed by Gabriel et al. [14] , in which a parametric model for the permittivity of blood is developed based on the data available in the literature. While the results from this study are commonly used to assess the safety of medical devices, primarily via specific absorption rate (SAR) calculations [15] , there are several limitations with the reported data. Specifically, the data presented is the averaged results from data collected from various research groups, and not all samples were from human blood samples. In [16] , blood samples from four volunteers were obtained and the broadband dielectric properties were recorded; however, there was no analysis performed to assess if a correlation existed between the permittivity of the blood and the components of the blood. Recently, it was shown that there is a strong correlation between changes in hematocrit and permittivity, [15] ; however, this work only used blood samples from a single individual and then synthetically varied the hematocrit by adding either plasma or RBCs from centrifuged blood samples [15] . Therefore, further work is required to add more clarity and certainty to the field. This paper presents two novel contributions. Firstly, the paper represents the largest ever study on the dielectric properties of human blood to date, providing useful insight on the expected range of properties. These properties are a unique platform for the development of future medical devices. Additionally, we compare the changes in blood components, based on laboratory results of the CBC, with changes in the broadband dielectric properties of over 170 blood samples from patients in a hematology clinic. Secondly, this paper demonstrates that a machine learning algorithm can be applied to permittivity measurements to create a highly specific and sensitive device that can detect the onset of anemia from simple measurements on whole blood without requiring any pre-processing.
The remainder of the paper is organized as follows: Section 2 presents the current state-of-the-art methods for anemia detection and recent advancements in novel detection methods; Section 3 describes the dielectric property measurement process, including how the blood samples were handled and the techniques used to ensure accuracy and validity, while minimizing the uncertainty associated with the measurement technique; The analysis of these permittivity measurements, and the development of a machine learning algorithm to classify changes in permittivity for anemia detection is presented in Section 4; Lastly, the paper concludes with a summary in Section 5.
II. BACKGROUND
In this section, a brief overview of the state-of-the-art methods for anemia detection, as well as potential low-cost alternatives, is presented. The cyanmethemoglobin method is an optical technique that is the current gold standard for assessing Hgb concentrations [1] , [3] . The principle behind the method is to create a unique optical spectral feature to allow the concentration of Hgb to be calculated. This process can be briefly summarized as follows: the whole blood is mixed with a solution containing potassium ferricyanide, the RBCs are lysed (the membrane of the red blood cell is broken down), and then the exposed Hgb is bound to the cyanide creating methemoglobin. This methemoglobin will exhibit a unique spectral absorption profile in the 530-550 nm range; thus it is common to use a 540 nm light source to characterize the absorbance of the sample and then calculate the Hgb concentration. This process requires dedicated laboratory equipment and a trained professional to operate the equipment.
As an alternative to the standard laboratory cyanmethemoglobin method, HemoCue have developed a point-of-care system, the HemoCue Hb series, for Hgb concentration measurements that targets screening for anemia in remote settings [3] , [6] . The device works by using specially designed microcuvettes that are placed into a HemoCue photometer that will then calculate and display the Hgb concentration. The microcuvettes are coated with dry reagents on the inner walls; these reagents will produce a modified azide methemoglobin reaction. The photometer will then measure the absorbance of the blood sample at two distinct wavelengths of 565 and 880 nm [6] . The system is battery operated, easy to use in the field, and there is little inter-observer error [3] . The HemoCue system has been identified by the WHO as an appropriate alternative to the direct cyanmethemoglobin method for surveys over large areas and testing in remote areas where adequate laboratories are not available [3] . However, the WHO has also identified several drawbacks with usage of the device: there are issues with the stability and longevity of cuvettes in regions of high humidity (must be used within a few days), the optical measurement is susceptible to false readings due to floating particles, and the overall cost remains a barrier for large-scale investigations [3] .
This work proposes the use of microwave measurement techniques, as opposed to the optical techniques described previously. The characterization of the dielectric properties of blood in the microwave range in this paper will provide insight on whether devices operating in this frequency range can be developed to address several primary concerns: specifically, those associated with the cost-per-test and the need for some chemical pre-processing of the blood sample. Recently, a study has investigated the use of a resonant cavity device operating at 9.4 GHz to measure Hgb concentration by correlating changes in permittivity with changes in Hgb concentration [7] . This sensor provides a non-destructive measurement technique that does not require lysing or chemical binding [7] . While this work demonstrated the strong correlation between changes in permittivity and Hgb, and the possibility to use a microwave device to monitor changes in Hgb concentration in murine rats, this work focused solely on measuring Hgb alone rather than whole blood measurements; the Hgb was isolated, via centrifuge, from the whole blood samples for testing. Thus, this device requires pre-processing of whole blood samples for accurate Hgb measurements.
The work in this paper focuses on direct measurements on human whole blood samples and characterizes the changes in permittivity in relation to the various components of blood; namely, Hgb, lymphocytes, platelets, sodium, and creatinine. We demonstrate that, of all the blood components, the change in Hgb is the biggest predictor of changes in permittivity, and that a machine learning algorithm can be trained with this data to accurately detect the onset of anemia from a simple permittivity measurement at a single frequency.
III. METHODS
Whole blood was collected from 176 patients, 80 male and 96 female patients, from various clinics, including hematology, oncology, and outpatient, at the University Hospital Galway. These patients were scheduled for routine blood tests; in accordance to ethical guidelines approved by the local ethics review board, one of the vacutainer tubes from each patient's blood draw was then set aside for the permittivity measurements. All patient data, except for gender, was anonymized by assigning each patient a coded study identification number. Venous blood samples were obtained and stored in standard 6 mL vacutainer tubes coated with ethylenediaminetetraacetic acid (EDTA). The remaining vacutainer tubes were sent for a complete blood count and further routine biochemical assessment in the Hematology Laboratory UHG. Hemoglobin measurements were performed in the Hematology Laboratory on samples using the Advia 2120i system (Bayer Healthcare Diagnostics Division) while the biochemistry assessments were performed on a serum sample in the Biochemistry Laboratory using the Cobas 8000 modular analyzer series from Roche Diagnostics. As the dielectric measurement research facility is colocated within the hospital, permittivity measurements were performed daily, as advised by the head clinician of the hematology clinic. Approximately 20 blood samples were collected each day and measurements were performed three times per week over a three-week period (9 total measurement days). The engineers recording the dielectric properties of the blood samples had no prior knowledge of the CBC for each sample, thus minimizing any bias in the measurement process.
Permittivity measurements were performed using the open-ended coaxial probe technique on whole blood samples without any manipulation or pre-processing of the blood sample. Data was collected using the Keysight slim form probe (2mm diameter coaxial probe) [17] connected to the Keysight E5063A Network Analyzer (NA). The probe was connected directly to the NA, mitigating any added uncertainty due to cable movement or repositioning [18] . To allow for accurate and repeatable positioning of the probe within the vacutainer, a combination of a vertical stand, and x-y positioning tables were used to control for x-y-z positioning of the sample. An image of this experimental setup is shown in Figure 1 .
The system was calibrated with a standard three-load oneport calibration (Air/Short/Deionized water) performed each day prior to measuring the blood samples. A validation measurement was performed after each calibration using 0.1 M NaCl solution (thus, a total of 9 validation measurements were performed). This validation was then used to calculate the total combined uncertainty, as defined in [19] . The validation was performed at room temperature, the temperature of the 0.1M NaCl solution was measured prior to each validation measurement, with a mean temperature of 23.6 • C (95 % CI, 23.1 -24.1). The uncertainty in the accuracy of the validation, VOLUME 6, 2018 as a percentage, is defined as:
where x meas refers to the measured properties of 0.1 M NaCl solution at each specific frequency point and x ref refers to the standard dielectric properties 0.1M NaCl as defined in [19] at the respective frequency point. The UNC ACC is calculated at each measured frequency point.
The uncertainty in the repeatability in the validation, defined as a percentage of how close to the average measured value a new measured value is expected to be, is defined as:
where x mean is the mean value of the measured parameter at that specific frequency point. The UNC REP is calculated at each measured frequency point, for each validation. The averaged uncertainty, across all validations measurements, is then reported for both the real and imaginary components of the permittivity. The average uncertainty in both accuracy and repeatability, along with the total combined uncertainty, are shown in the Table 1: All measurements were performed once the blood samples reached room temperature, the temperature of each blood sample was taken prior to each measurement with a mean temperature of 24.1 • C (95 % CI, 23.3 -24.9). Three measurements were taken from each blood sample, with 201 data points taken over the 500 MHz -8.5 GHz range. Past works have demonstrated that the change in permittivity is less than 1% per • C [20] ; therefore, as the range for these measurements is within ± 1 • C, no compensation for temperature was performed.
IV. RESULTS
First, we examined whether or not the data from the different genders could be combined or not. A two-sample t-test was carried out comparing the distributions of the measured dielectric properties of 80 male and 80 female (reduced to ensure equal number of observations in both classes, the 80 female sample were chosen at random) blood samples. A p-value > 0.05 was calculated; thus the null hypothesis was not rejected, and the analysis can be carried out assuming that the measured dielectric properties of the blood samples collected from both genders come from distributions that are not significantly different. Therefore, the analysis in this paper does not separate for gender.
Next, in order to identify which components of blood contribute most significantly to changes in the permittivity, a multiple linear regression analysis was performed. A linear regression model, for both the real and imaginary components of the permittivity (at a single frequency, in this example 1 GHz was chosen), was created in MATLAB to correlate changes in the blood components with changes in the measured permittivity. Access to the CBC information allowed us to correlate the changes in permittivity with changes in Hgb, lymphocytes, platelets, sodium, and creatinine. A linear regression model for the real part of the permittivity, r , can be defined as:
where k x refers to the parameter estimate that leads to the best fit for that specific component of blood. In this model, the units for Hgb, lymphocytes, platelets, sodium, and creatinine are, g/dL, number of cells x 10 9 /L, number of cells x 10 9 /L, milliequivalents per liter (mEq/L), and micromoles per liter, respectively. The fitlm function was used to generate an estimate of these parameters that lead to the best fit model, as well as providing an estimate on the significance on the contribution, from a p-value statistic (here a p-value < 0.01 was considered to be statistically significant). These values are shown in Table 2 . The linear regression model had an R 2 value of 0.932, demonstrating that there is strong linear relationship between changes in the blood components and changes in the real part of the permittivity. Most significantly, it was observed that Hgb had the highest level of significance by far of all blood components; with only the lymphocytes concentration also providing a contribution that was statistically significant. A similar analysis was performed for the imaginary component of the permittivity, with a linear regression model for the imaginary component, ε , defined as:
where l x refers to the parameter estimate that leads to the best fit for that specific component of blood. Once again, the fitlm function was used, with the corresponding values for the imaginary component of permittivity shown in Table 3 . The linear regression model had an R 2 value of 0.740. While this represents a reasonably good fit, it demonstrates that these components of the blood do not represent changes in the imaginary component of the permittivity as well as they represent changes in the real component. As with the real component of permittivity, it was Hgb that had the highest statistical significance. However, for the imaginary component, the sodium concentration also played a statistically significant role in changes in the complex permittivity. This result agrees with the expected outcome that sodium concentration play a direct role in conductivity changes.
An example that demonstrates the correlation between changes in Hgb concentration and measured r , at 1 GHz, of whole blood samples is shown in Figure 2 . For comparison, the correlation between the lymphocytes concentration and changes in the measured r , at 1 GHz, is also shown in Figure 2 . It is apparent from these plots that there is a very strong correlation between changing permittivity and Hgb, with an R 2 value of 0.908, while the correlation between the lymphocyte concentration (the only other statistically significant contribution to the model) and measured r is much weaker with an R 2 value of 0.520.
From this linear regression analysis, it is clear that there exists a strong correlation between the measured dielectric properties of unprocessed, human, whole blood samples and the Hgb level. Using a definition of anemia as a Hgb concentration of <12.0 g/dL, as defined by the WHO in [3] , it was possible to separate all the measured properties into two groups; those samples from patients with anemia and healthy patients. With this definition, of the 176 patient blood samples, 73 came from patients with anemia and 103 came from healthy patients. In Figure 3 , we compare the real and imaginary permittivity values across the entire frequency band measured, 0.5 -8.5 GHz, for both patient populations. All of the measured samples are included in this figure, thus the distribution of all samples in each patient population is shown. The curves in the plot are color coded based on the corresponding Hgb concentration, with low Hgb corresponding to a green color and the normal range corresponding to the blue colored curves. Figure 3 demonstrates that there appears to be a distinct separation between the measured dielectric properties of the anemic samples and the samples from nonanemic patients.
Furthermore, in Figure 4 we compare the mean measured dielectric property values for both the anemia and healthy patient groups at specific frequencies; 1, 3, 5, and 7 GHz respectively. The error bars in the figures represent the standard deviation. It is clear that the differences in the real and imaginary permittivity are consistent and statistically significant across the entire frequency band. Additionally the standard deviation at each frequency point is a small fraction of the mean measured permittivity values, thus we can expect minimal overlap in the permittivity values of blood samples from healthy patients and patients with anemia, highlighting the possibility for successful classification of anemia based on permittivity measurements at a single frequency.
These differences in permittivity between the two populations highlights the possibility of using a resonant (single frequency) device to calculate Hgb concentration based on a permittivity characterization of a blood sample. In order to assess the feasibility of such a device, the permittivity measurements at a single frequency will be used in conjunction with a machine learning algorithm to create a prediction model that uses permittivity measurements to predict the onset of anemia.
A. MACHINE LEARNING FOR ANEMIA DETECTION
Support vector machines (SVM) is a machine learning algorithm that can be used for binary classification [21] , in this case, whether a blood sample is from a healthy patient or a patient with anemia. An SVM-classifier must first be trained in order to predict the outcome classes. The real and imaginary components of the permittivity of whole blood at 1 GHz can be used as the two input features for the SVM-classifier. The training data is taken as 90% of the complete data set. The final SVM model parameters are found by performing 10-fold cross validation using Bayesian optimization to determine the ideal kernel scale and box constraint using radial basis function as the kernel for SVM classifier. Once these optimized parameters are found they are used to train the final SVM classifier that will be used to predict the classes of the test data. A visualization of the optimized classifier, the training data, as well as the prediction probabilities is shown in Figure 5 . This plot shows the measured training data points (blue dots for the anemia population, red dots for the healthy population), and the deciding plane that separates the two classes. The heat map in Figure 5 represents the probability of assigning a new measurement point to one of the two classes. As a new data point approaches the decision plane, approximately defined as the black region where the decision probability approaches 50%, the assigned probability to one class or the other decreases; the closer to the decision plane the less certain the classifier is in its decision. The final trained classifier is then tested with the remaining 10% of the data that was excluded from the cross-validation process, to ensure the results are generalizable to future cases. This process of training and testing is repeated ten times and the results are averaged, to obtain a representative measure of the performance of the classifier. The averaged results across all cases show a classifier with 96.89% ± 6.89% sensitivity and 94.56% ± 10.74 % specificity; which would represent an increase in sensitivity of over 10% in comparison to the HemoCue system [3] . Additionally, it is also possible to use a trained linear regression model to both estimate the Hgb concentration and detect anemia from a single frequency permittivity value, as demonstrated earlier in Section 4. A linear regression model was trained using all 176 blood samples. These same samples were then used to calculate the average error in the estimated Hgb concentration and the sensitivity and specificity. The linear regression model had a mean squared error of 0.597 g/dL in the estimated Hgb concentration, with a sensitivity of 92.3% and specificity of 98.6%.
V. CONCLUSION
This paper presented a large-scale study in the variation in the dielectric properties of human blood over a wide frequency band, correlated changes in the blood components with changes in permittivity, and demonstrated that permittivity data from a single frequency point can be used to train a SVM classifier that is highly sensitive and specific for anemia detection.
This study measured the dielectric properties from 176 patients, with 80 samples from male patients and 96 from female patients and demonstrated that the changes in the measured permittivity of these blood samples correlate strongest with changes in the Hgb concentration. These results can help inform medical device development interested in assessing how blood can impact the safety and performance of specific devices; specifically, these results help provide the expected limits on the dielectric properties of human blood across a wide frequency range.
In this work, we demonstrate that using the permittivity data at a single frequency of 1 GHz, a simple two-feature SVM algorithm can be used to detect anemia with 96.89% sensitivity and 94.56% specificity. This results encourages the development of smaller, low-cost devices that can measure the permittivity of small blood volumes for anemia detection. Future work involves designing a small microfluidic resonant device, potentially operating at 1 GHz, and testing its performance in detecting changes in Hgb.
Future work involves investigated developing devices at known standard operating frequencies, such as 915 MHz, 2.4 GHz, and 5.2 GHz, where RF electronics are readily available. The results from this work imply that the difference between anemic and healthy observations are significant across the frequency band and can be extended to these frequencies. Furthermore, we intend to explore the idea of multi-class classification to identify when hemoglobin falls below 8g/dL, which is the threshold for when transfusion is necessary; thus, we can have a device that not only detects anemia but can also give a warning when transfusion would be required.
